Marker Therapeutics Inc. (MRKR) is priced at $0.40 after the most recent trading session. At the very opening of the session, the stock price was $0.35 and reached a high price of $0.4227, prior to closing the session it reached the value of $0.34. The stock touched a low price of $0.3015.
Marker Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.4227 on 01/24/23, with the lowest value was $0.2520 for the same time period, recorded on 01/03/23.
Marker Therapeutics Inc. (MRKR) full year performance was -33.17%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Marker Therapeutics Inc. shares are logging -40.15% during the 52-week period from high price, and 82.27% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.22 and $0.67.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1541243 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Marker Therapeutics Inc. (MRKR) recorded performance in the market was 50.81%, having the revenues showcasing 2.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 33.17M, as it employees total of 56 workers.
The Analysts eye on Marker Therapeutics Inc. (MRKR)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3501, with a change in the price was noted +0.10. In a similar fashion, Marker Therapeutics Inc. posted a movement of +33.31% for the period of last 100 days, recording 434,387 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MRKR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Marker Therapeutics Inc. (MRKR)
Raw Stochastic average of Marker Therapeutics Inc. in the period of last 50 days is set at 89.29%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.29%. In the last 20 days, the company’s Stochastic %K was 76.64% and its Stochastic %D was recorded 71.27%.
Considering, the past performance of Marker Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 50.81%. Additionally, trading for the stock in the period of the last six months notably improved by 19.24%, alongside a downfall of -33.17% for the period of the last 12 months. The shares increased approximately by 14.44% in the 7-day charts and went down by 40.75% in the period of the last 30 days. Common stock shares were driven by 2.24% during last recorded quarter.